GO:0035578 azurophil granule lumen: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035578 azurophil granule lumen is the volume enclosed by the membrane of an azurophil granule, a primary lysosomal granule in neutrophil granulocytes.
• The azurophil granule lumen is enriched in hydrolytic enzymes and antimicrobial proteins such as myeloperoxidase and bactericidal/permeability-increasing protein (BPI).
• Azurophil granule components are released into the extracellular fluid upon neutrophil activation, contributing to host defense and tissue damage.
• Dysregulation of azurophil granule lumen content is linked to inflammatory diseases including cystic fibrosis and ankylosing spondylitis.
• Experimental models for studying the azurophil granule lumen include knockout, knock-in, and overexpression cell lines, as well as CRISPR library screening.
• Key methods to investigate this compartment include proteomics, imaging, and functional assays in neutrophil-like cells.
Description
The azurophil granule lumen (GO:0035578) is a specialized subcellular compartment within neutrophil granulocytes, defined as the volume enclosed by the membrane of an azurophil granule, a primary lysosomal granule that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid. This compartment is central to the antimicrobial and inflammatory functions of neutrophils, as it stores and releases potent enzymes and proteins that combat pathogens but can also damage host tissues when dysregulated. Understanding the azurophil granule lumen is therefore critical for researchers studying innate immunity, inflammation, and related diseases. The lumen's composition and dynamics have been characterized through ultrastructural and biochemical studies, revealing a complex mixture of proteases, antimicrobial peptides, and membrane-associated proteins. Recent advances in CRISPR-based gene editing and high-throughput screening now allow precise interrogation of the genes that regulate azurophil granule lumen formation and function, opening new avenues for therapeutic intervention in inflammatory disorders.
azurophil granule lumen At A Glance
| GO ID | GO:0035578 |
|---|---|
| GO term | azurophil granule lumen |
| Ontology | cellular_component |
| Synonym | primary granule lumen |
| Major function | Storage and release of hydrolytic enzymes and antimicrobial proteins |
| Cellular location | Neutrophil granulocytes |
| Related compartment | Azurophil granule (primary lysosome) |
| Release mechanism | Exocytosis into extracellular fluid upon activation |
What Is GO:0035578?
The azurophil granule lumen is the interior space of an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes. This lumen contains a wide range of hydrolytic enzymes and is released into the extracellular fluid upon cellular activation. It is synonymous with the primary granule lumen.
Why Is azurophil granule lumen Important in Cell Biology?
The azurophil granule lumen is essential for neutrophil-mediated host defense, as it concentrates and releases enzymes that kill pathogens. However, excessive or misplaced release of its contents contributes to inflammatory tissue damage in diseases such as cystic fibrosis and ankylosing spondylitis. Studying this compartment helps elucidate mechanisms of innate immunity and identify therapeutic targets for inflammatory conditions.
• Central to neutrophil antimicrobial activity.
• Source of myeloperoxidase, a key enzyme in oxidative burst.
• Contains BPI, which neutralizes endotoxin and kills bacteria.
• Dysregulated release linked to cystic fibrosis airway inflammation.
• Implicated in ankylosing spondylitis hip arthropathy.
• Target for anti-inflammatory drug development.
• Model system for lysosome-related organelle biogenesis.
• Relevant to leukemia-associated granule abnormalities.
• Studied using ultrastructural and cytochemical methods.
What Happens During azurophil granule lumen?
Granule formation and lumen maturation
In simple terms: The azurophil granule lumen forms as the granule matures inside neutrophils.
Azurophil granules originate from the trans-Golgi network during neutrophil differentiation. The lumen acquires its characteristic hydrolytic enzymes, including myeloperoxidase, which is processed post-translationally in a heme-dependent manner. The membrane of the granule encloses this lumen, creating a specialized environment for enzyme storage.
Enzyme packaging and storage
In simple terms: Enzymes are packed into the lumen and kept inactive until needed.
The azurophil granule lumen concentrates a wide range of hydrolytic enzymes and antimicrobial proteins. BPI is membrane-associated within azurophil granules and relocates upon cellular activation. Myeloperoxidase is a major luminal component, and its processing is regulated by heme availability.
Activation and release
In simple terms: When neutrophils are activated, the lumen contents are released outside the cell.
Upon stimulation, azurophil granules fuse with the plasma membrane or phagosome, releasing their luminal contents into the extracellular fluid or phagosomal lumen. This release is critical for killing pathogens but can also cause tissue damage, as seen in inflammatory conditions.
Extracellular functions
In simple terms: Released enzymes act outside the cell to fight microbes and modulate inflammation.
After release, enzymes such as myeloperoxidase and BPI retain functional properties and can bind to extracellular DNA, as shown for the chemokine GCP-2/CXCL6 in cystic fibrosis airways. This binding may modulate chemokine activity and inflammatory responses.
Key Genes Involved in GO:0035578 azurophil granule lumen
The following genes and proteins are key components or regulators of the azurophil granule lumen, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MPO | Myeloperoxidase enzyme in lumen | Antimicrobial and oxidative burst; linked to ankylosing spondylitis |
| BPI | Bactericidal/permeability-increasing protein | Membrane-associated in azurophil granules; endotoxin neutralization |
| CXCL6 | Chemokine GCP-2 | Expressed in cystic fibrosis airways; binds extracellular DNA |
| ELANE | Neutrophil elastase | Major luminal protease; host defense and tissue damage |
| PRTN3 | Proteinase 3 | Luminal protease; autoantigen in vasculitis |
| CTSG | Cathepsin G | Luminal protease; antimicrobial and inflammatory |
| AZU1 | Azurocidin | Antimicrobial protein in azurophil granules |
| DEFB1 | Beta-defensin 1 | Antimicrobial peptide in neutrophil granules |
| LYZ | Lysozyme | Hydrolytic enzyme in lumen |
| SERPINB1 | Serpin B1 | Regulates neutrophil serine proteases |
| RAB27A | Rab GTPase | Regulates granule exocytosis |
| STXBP2 | Syntaxin binding protein 2 | Required for granule fusion |
| UNC13D | Munc13-4 | Regulates granule priming and release |
| SNAP23 | Synaptosomal-associated protein 23 | SNARE protein in granule exocytosis |
| VAMP7 | Vesicle-associated membrane protein 7 | SNARE protein for azurophil granule fusion |
| LAMP1 | Lysosomal-associated membrane protein 1 | Membrane marker of azurophil granules |
| CD63 | Lysosomal membrane protein | Marker of azurophil granules |
How Is azurophil granule lumen Regulated?
The formation and release of the azurophil granule lumen are regulated at multiple levels. Transcription factors such as C/EBPε and PU.1 control granule protein gene expression during granulopoiesis. Post-translational processing, such as heme-dependent myeloperoxidase maturation, determines luminal enzyme activity. Exocytosis is regulated by Rab GTPases, SNARE proteins, and calcium signaling. Inflammatory mediators can trigger premature release, contributing to tissue damage.
azurophil granule lumen and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MPO | Ankylosing spondylitis hip arthropathy | MPO knockout neutrophil-like cells |
| CXCL6 | Cystic fibrosis airway inflammation | CXCL6 overexpression in airway epithelial cells |
| BPI | Sepsis and endotoxin shock | BPI knock-in mice or cell lines |
| ELANE | Severe congenital neutropenia | ELANE point mutation in iPSC-derived neutrophils |
| RAB27A | Griscelli syndrome | RAB27A knockout in neutrophil-like HL-60 cells |
Ankylosing spondylitis and hip arthropathy
Abnormal myeloperoxidase and phagosome function in neutrophils contribute to hip arthropathy in ankylosing spondylitis, highlighting the role of azurophil granule lumen components in inflammatory joint disease.
Cystic fibrosis airway inflammation
In cystic fibrosis, the chemokine GCP-2/CXCL6 is expressed in airways and binds to extracellular DNA, retaining functional properties. This interaction may perpetuate neutrophil recruitment and inflammation, linking azurophil granule lumen contents to disease pathology.
Acute myeloid leukemia
Acute coronary syndrome in acute myeloid leukemia with maturation and megakaryocytic differentiation suggests that abnormal granule formation and release may contribute to thrombotic complications.
Pulmonary microvascular injury
Infusion of zymosan-activated plasma in sheep causes pulmonary microcirculation changes, likely due to neutrophil granule release, demonstrating the pathophysiological impact of azurophil granule lumen contents.
From azurophil granule lumen-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MPO deficiency alter azurophil granule lumen content? | MPO knockout neutrophil-like cells |
| How does BPI membrane association affect bacterial killing? | BPI knock-in or tagged knock-in in HL-60 cells |
| What is the role of CXCL6 in cystic fibrosis inflammation? | CXCL6 overexpression in airway epithelial cells |
| How do point mutations in ELANE affect granule formation? | ELANE point mutation in iPSC-derived neutrophils |
| Can CRISPR library screening identify regulators of granule exocytosis? | Genome-wide CRISPR knockout library in neutrophil-like cells |
| Does tagged LAMP1 correctly localize to azurophil granule lumen? | LAMP1 knock-in with fluorescent tag in HL-60 cells |
How to Study the azurophil granule lumen Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Proteomics | Protein composition of granule lumen | Identify novel luminal proteins |
| Electron microscopy | Ultrastructure of granules | Visualize granule morphology |
| Enzyme activity assay | Myeloperoxidase or elastase activity | Quantify release upon activation |
| Flow cytometry | Surface markers of granule fusion | Assess exocytosis |
| CRISPR knockout screening | Gene essentiality for granule formation | Discover regulators |
| RNA-seq | Transcriptional changes during granulopoiesis | Identify granule gene expression programs |
| Immunofluorescence | Localization of luminal proteins | Confirm granule targeting |
| ELISA | Concentration of released proteins | Measure extracellular release |
Proteomic profiling of azurophil granule lumen
Mass spectrometry-based proteomics can identify and quantify proteins within isolated azurophil granules, revealing the composition of the lumen and changes under disease conditions.
Imaging and ultrastructural analysis
Electron microscopy and cytochemistry visualize azurophil granules and their luminal contents, as demonstrated in studies of peroxidase-positive granules.
Functional assays for enzyme release
Enzyme-linked immunosorbent assays and activity assays measure the release of myeloperoxidase, elastase, and other luminal components upon neutrophil activation.
CRISPR screening for regulators
Genome-wide CRISPR knockout screens in neutrophil-like cell lines can identify genes required for azurophil granule lumen formation, maturation, and exocytosis.
How CRISPR Can Be Used to Study GO:0035578 azurophil granule lumen
Knockout
CRISPR knockout of genes such as MPO or BPI in neutrophil-like cell lines can reveal their roles in azurophil granule lumen formation and function. For example, MPO knockout models help study the contribution of myeloperoxidase to inflammatory diseases.
Point Mutation
Introducing point mutations in genes like ELANE or RAB27A allows researchers to model disease-associated variants and study their effects on granule exocytosis and lumen content.
Knock-in
Knock-in of tagged versions of luminal proteins, such as LAMP1 or BPI, enables live-cell imaging and tracking of azurophil granule dynamics.
Overexpression
Overexpression of chemokines like CXCL6 in airway epithelial cells can mimic cystic fibrosis-associated inflammation and study interactions with extracellular DNA.
How EDITGENE Supports azurophil granule lumen Research
Researchers studying azurophil granule lumen-related genes often need to determine whether a candidate gene is causally involved in granule formation, release, or disease pathogenesis. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for azurophil granule lumen research.
Frequently Asked Questions About azurophil granule lumen
What is the azurophil granule lumen?
The azurophil granule lumen is the interior space of an azurophil granule, a primary lysosomal granule in neutrophils that contains hydrolytic enzymes and is released into the extracellular fluid.
What genes are involved in azurophil granule lumen?
Key genes include MPO, BPI, ELANE, PRTN3, CTSG, and CXCL6, among others.
What is the function of azurophil granule lumen?
It stores and releases antimicrobial enzymes and proteins that kill pathogens and modulate inflammation.
How is azurophil granule lumen related to disease?
Dysregulated release contributes to inflammatory diseases such as cystic fibrosis and ankylosing spondylitis.
What is the GO ID for azurophil granule lumen?
The GO ID is GO:0035578.
What are synonyms for azurophil granule lumen?
The synonym is primary granule lumen.
How can I study azurophil granule lumen using CRISPR?
CRISPR knockout, knock-in, point mutation, and overexpression models in neutrophil-like cells enable functional studies.
What methods are used to analyze azurophil granule lumen?
Proteomics, electron microscopy, enzyme activity assays, and CRISPR screening are commonly used.
Which cell types contain azurophil granule lumen?
Neutrophil granulocytes contain azurophil granules with this lumen.
What proteins are found in azurophil granule lumen?
Myeloperoxidase, BPI, neutrophil elastase, proteinase 3, cathepsin G, and lysozyme are examples.
Conclusion
The azurophil granule lumen (GO:0035578) is a critical compartment in neutrophil biology, storing and releasing potent enzymes that defend against pathogens but can also drive inflammatory pathology. Understanding its regulation and function through CRISPR-based models and advanced methods offers insights into diseases such as cystic fibrosis and ankylosing spondylitis. EDITGENE provides the tools to accelerate this research.
References
- 1. Yu C et al.. 2021. Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome.. Front Immunol 12:572592 PMID: 34880852
- 2. Calafat J et al.. 2000. The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation.. APMIS 108(3):201-8 PMID: 10752689
- 3. Jovic S et al.. 2016. The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.. Mucosal Immunol 9(1):112-23 PMID: 25993443
- 4. Odani K et al.. 2020. Acute Coronary Syndrome in Acute Myeloid Leukemia with Maturation Accompanying Megakaryocytic Differentiation.. Case Rep Pathol 2020:8886298 PMID: 33014496
- 5. Pinnix IB et al.. 1994. The post-translational processing of myeloperoxidase is regulated by the availability of heme.. Arch Biochem Biophys 312(2):447-58 PMID: 8037458
- 6. Meyrick BO et al.. 1984. The effect of a single infusion of zymosan-activated plasma on the pulmonary microcirculation of sheep. Structure-function relationships.. Am J Pathol 114(1):32-45 PMID: 6691415
- 8. Blinzinger K et al.. 1978. Ultrastructural cytochemical demonstration of peroxidase-positive monocyte granules: an additional method for studying the origin of mononuclear cells in encephalitic lesions.. Acta Neuropathol 43(1-2):55-61 PMID: 676687
